Compare LENZ & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LENZ | CFBK |
|---|---|---|
| Founded | 2019 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.8M | 178.1M |
| IPO Year | 2021 | 2005 |
| Metric | LENZ | CFBK |
|---|---|---|
| Price | $5.57 | $31.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $44.00 | $31.50 |
| AVG Volume (30 Days) | ★ 610.6K | 56.3K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 1.23% |
| EPS Growth | N/A | ★ 30.58 |
| EPS | N/A | ★ 0.77 |
| Revenue | ★ $19,088,000.00 | N/A |
| Revenue This Year | $50.42 | $31.99 |
| Revenue Next Year | $197.16 | $9.09 |
| P/E Ratio | ★ N/A | $39.87 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.73 | $22.10 |
| 52 Week High | $50.19 | $34.34 |
| Indicator | LENZ | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 26.32 | 67.47 |
| Support Level | N/A | $28.40 |
| Resistance Level | $10.42 | $31.70 |
| Average True Range (ATR) | 0.43 | 0.95 |
| MACD | -0.05 | 0.08 |
| Stochastic Oscillator | 0.56 | 82.47 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.